patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: yahoo news:PSTI PLX Cells One Step Closer to Entering Japan's Accelerated Path

Pluristem's PLX Cells One Step Closer to Entering Japan's Accelerated Pathway for Regenerative Medicine

Pluristem Completes Successful Meeting With PMDA and Satisfies Critical Prerequisite for Initiation of Clinical Study Targeting Fast-Track Approval in Japan

Share
New Message
Please login to post a reply